Muhammad Rayan Alamiry, M.d
Chronic disease →Telehealth platform
Independent
Session types
Video
Languages
English
Are you Muhammad Rayan Alamiry, M.d?
Claim your profile to verify your insurance, update your bio, add your booking link, and get a Verified badge that builds patient trust. Free tier goes live instantly — no card required.
Claim your profileLooking for a patient? Here's what to know
This profile shows public registry data — name, specialty, and licensed states are confirmed via the federal NPI database. Insurance accepted, current bio, and booking links haven't been confirmed by Muhammad yet. To verify if they take your insurance or are accepting new patients, contact their practice directly.
About
Dr. Muhammad Rayan Alamiry specializes in helping patients manage complex chronic conditions through evidence-based medical care delivered via telehealth. He works with individuals navigating type 2 diabetes, hypertension, and heart disease, focusing on long-term disease management and medication optimization. Dr. Alamiry is committed to making specialized chronic disease care accessible to patients throughout Pennsylvania via virtual visits.
Services offered
Dr. Alamiry provides comprehensive telehealth management for patients with multiple chronic conditions including diabetes, cardiovascular disease, respiratory conditions, and endocrine disorders. During virtual appointments, he conducts detailed assessments, reviews lab results and vital signs, adjusts medications when appropriate, and develops personalized treatment plans tailored to each patient's specific health goals and lifestyle. He emphasizes medication therapy management, lifestyle modification coaching, and regular monitoring to help patients achieve better disease control and prevent complications. Dr. Alamiry is especially skilled at managing patients with overlapping conditions who require coordinated care across multiple disease states, working to optimize overall health outcomes through evidence-based chronic disease management strategies.